Dear all,
My lab at the IBS in Grenoble has a fully funded 3-year PhD position to develop novel antifungal compounds targeting an essential epigenetic pathway in the emerging fungal pathogen
Candida auris, designated as a critical priority by the World Health Organization.
Candida auris, designated as a critical priority by the World Health Organization.
The work combines structure-based drug discovery using crystallography with biochemical, biophysical and cell-based approaches.
More details and how to apply can be found here:
https://www.abg.asso.fr/en/candidatOffres/show/id_offre/137794/job/phd-position-developing-a-novel-class-of-antifungal-drugs-against-a-multidrug-resistant-fungal-pathogen
https://www.abg.asso.fr/en/candidatOffres/show/id_offre/137794/job/phd-position-developing-a-novel-class-of-antifungal-drugs-against-a-multidrug-resistant-fungal-pathogen
I would appreciate it if you could share this with any potentially interested candidates.
Applications will be reviewed on a rolling basis. Deadline: May 17, 2026.
Many thanks!
Carlo
Carlo
Carlo Petosa
Institut de Biologie Structurale
38044 Grenoble Cedex 9 France
Tel. +33 (0)4 57 42 86 17
email: carlo.petosa@ibs.fr